Recreational, abused drugs (e.g., cannabinoids; cocaine; and MDMA/ecstasy) appear to increase dopaminergic signaling in the mesolimbic reward pathway which, in turn, reinforces the subjective rewarding, and euphoric effects ...
Oct 2, 2020
1
4
Boston Medical Center's (BMC) psychiatry team is studying a drug called lorcaserin, which targets the brain's serotonin receptors and could help reduce cocaine cravings as well as dampen the rewards associated with taking ...
Sep 20, 2017
0
1
A new article in JAMA Psychiatry details the first step in revealing how craving works in the brain. Scientists at the Center for BrainHealth at The University of Texas at Dallas are the first to propose a systematic and ...
May 3, 2017
0
6
Federal health advisers recommended approval Tuesday for an experimental implant designed to treat patients recovering from heroin and painkiller addiction.
Jan 12, 2016
0
0
Playing Tetris for as little as three minutes at a time can weaken cravings for drugs, food and activities such as sex and sleeping by approximately one fifth, according to new research published this week.
Aug 13, 2015
0
187
Neuroscientists at Western University (London, Canada) have made a remarkable new discovery revealing the underlying molecular process by which opiate addiction develops in the brain. Opiate addiction is largely controlled ...
Sep 10, 2013
0
0
The drug topiramate, typically used to treat epilepsy and more recently weight loss, may also help people addicted to both cocaine and alcohol use less cocaine, particularly heavy users, researchers in the department of Psychiatry ...
Jul 18, 2013
0
2
A new study conducted by a team of Indiana University neuroscientists demonstrates that GLT1, a protein that clears glutamate from the brain, plays a critical role in the craving for cocaine that develops after only several ...
Jun 3, 2013
2
0
Neurological disorders can have a devastating impact on the lives of sufferers and their families.
May 17, 2013
0
0
(Medical Xpress)—Researchers at the Aptuit Centre for Drug Discovery and Development in Italy, have found that a drug called GSK598809 is able to block a type of dopamine receptor in the brain that has been linked to nicotine ...
